Bio-Techne Corp
TECH
Market Cap$12.55B
Close$
$39.64
51% downside
Current Fair Value
51% downsideOvervalued by 51% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.55 Billion |
|---|---|
| Enterprise Value | $12.79 Billion |
| Dividend Yield | $0.3189 (0.4%) |
| Earnings per Share | $1.26 |
| Beta | 1.05 |
| Outstanding Shares | 157,584,637 |
| Avg 30 Day Volume | 1,223,056 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 61.82 |
|---|---|
| PEG | -205.23 |
| Price to Sales | 11.56 |
| Price to Book Ratio | 6.74 |
| Enterprise Value to Revenue | 11.08 |
| Enterprise Value to EBIT | 51.52 |
| Enterprise Value to Net Income | 63 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
ESG Score
No data
About Bio-Techne Corp
2,100 employees
CEO: Charles Kummeth Bio-Techne Corporation is a holding company for biotechnology and clinical diagnostic brands. It was founded in 1976 as Techne Corporation and changed its name to Bio-Techne in 2014. The company's brands include flagship R&D Systems , No...